Evaluation of the current disease severity scores in paediatric FMF: is it necessary to develop a new one?

Gokhan Kalkan1, Erkan Demirkaya, Cengiz Han Acikel

  • 1FMF Arthritis Vasculitis and Orphan Disease Research in Paediatric Rheumatology (FAVOR), Department of Paediatrics, Pediatric Nephrology and Rheumatology Unit, Gulhane Military Medical Faculty, School of Medicine, 06018 Etlik, Ankara, Turkey.

Insights

Modified adult scoring systems lack consistency for childhood Familial Mediterranean Fever (FMF). Disease severity scores did not correlate with FMF mutation types in pediatric patients, questioning their reliability.

Area of Science:

  • Pediatric Rheumatology
  • Genetics
  • Clinical Scoring Systems

Background:

  • Modified adult disease severity scoring systems are increasingly used for pediatric Familial Mediterranean Fever (FMF).
  • The reliability of these adapted systems in children with FMF is not well-established.
  • Specific FMF mutations are known to be associated with disease severity.

Purpose of the Study:

  • To assess the clinical consistency of two common modified adult FMF severity scoring systems in pediatric patients.
  • To evaluate the correlation between FMF mutation types and disease severity scores in children.
  • To determine the suitability of current scoring systems for pediatric FMF management.

Main Methods:

  • Cross-sectional study of 258 children diagnosed with FMF.
  • Disease severity assessed using modified Mor et al. and Pras et al. scoring systems.
  • Genetic analysis for 15 FMF mutations, grouped by known genotypic-phenotypic associations.

Main Results:

  • The two scoring systems demonstrated poor statistical consistency (κ=0.171), even in a subgroup of patients with homozygous mutations (κ=0.125).
  • No significant correlation was found between FMF mutation groups and scores from either the Mor et al. or Pras et al. systems.
  • Statistical analysis revealed a lack of association between genotype and the assessed disease severity.

Conclusions:

  • The evaluated scoring systems show significant inconsistency and lack of correlation with FMF mutation types in children.
  • Concerns exist regarding the reliability of these modified adult scoring systems for pediatric FMF.
  • Development of a novel, pediatric-specific FMF scoring system based on a prospective registry is warranted.
Abstract